483 related articles for article (PubMed ID: 21170538)
1. The pathological process underlying Alzheimer's disease in individuals under thirty.
Braak H; Del Tredici K
Acta Neuropathol; 2011 Feb; 121(2):171-81. PubMed ID: 21170538
[TBL] [Abstract][Full Text] [Related]
2. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
Braak H; Thal DR; Ghebremedhin E; Del Tredici K
J Neuropathol Exp Neurol; 2011 Nov; 70(11):960-9. PubMed ID: 22002422
[TBL] [Abstract][Full Text] [Related]
3. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
4. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence.
Uchihara T; Nakamura A; Yamazaki M; Mori O
Acta Neuropathol; 2001 Jun; 101(6):535-9. PubMed ID: 11515780
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
6. Where, when, and in what form does sporadic Alzheimer's disease begin?
Braak H; Del Tredici K
Curr Opin Neurol; 2012 Dec; 25(6):708-14. PubMed ID: 23160422
[TBL] [Abstract][Full Text] [Related]
7. Early Alzheimer-type lesions in cognitively normal subjects.
Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
[TBL] [Abstract][Full Text] [Related]
8. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.
Braak H; Del Tredici K
Brain; 2015 Oct; 138(Pt 10):2814-33. PubMed ID: 26283673
[TBL] [Abstract][Full Text] [Related]
9. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease.
Nakano H; Kobayashi K; Sugimori K; Shimazaki M; Miyazu K; Hayashi M; Furuta H
Dement Geriatr Cogn Disord; 2004; 17(3):122-31. PubMed ID: 14739532
[TBL] [Abstract][Full Text] [Related]
10. Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease.
Blazquez-Llorca L; Garcia-Marin V; Merino-Serrais P; Ávila J; DeFelipe J
J Alzheimers Dis; 2011; 26(4):683-98. PubMed ID: 21677375
[TBL] [Abstract][Full Text] [Related]
11. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.
Kobayashi K; Nakano H; Hayashi M; Shimazaki M; Fukutani Y; Sasaki K; Sugimori K; Koshino Y
J Neurol Sci; 2003 Apr; 208(1-2):17-24. PubMed ID: 12639720
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
[TBL] [Abstract][Full Text] [Related]
13. Evolutional aspects of Alzheimer's disease pathogenesis.
Braak H; Del Tredici K
J Alzheimers Dis; 2013; 33 Suppl 1():S155-61. PubMed ID: 22699850
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
15. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.
Braak H; Zetterberg H; Del Tredici K; Blennow K
Acta Neuropathol; 2013 Nov; 126(5):631-41. PubMed ID: 23756600
[TBL] [Abstract][Full Text] [Related]
16. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
17. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
18. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
[TBL] [Abstract][Full Text] [Related]
19. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
20. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
Brici D; Götz J; Nisbet RM
J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
